Novo Nordisk A/S (ETR:NOV)
Germany · Delayed Price · Currency is EUR 49.00
-1.80 (-3.54%)
Oct 10, 2025, 10:50 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of €224.36 billion as of October 10, 2025. Its market cap has decreased by -54.95% in one year.
Market Cap
224.36B
Enterprise Value
235.13B
Revenue
41.82B
Ranking
n/a
PE Ratio
15.07
Stock Price
€49.00
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 6.23B to 224.36B, an increase of 3,503.27%. That is a compound annual growth rate of 13.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 224.36B | -39.66% |
| Dec 30, 2024 | 371.85B | -10.95% |
| Dec 29, 2023 | 417.56B | 46.59% |
| Dec 30, 2022 | 284.85B | 26.44% |
| Dec 30, 2021 | 225.29B | 69.93% |
| Dec 30, 2020 | 132.58B | 8.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 52.54B |
| Merck KGaA | 50.48B |
| Bayer Aktiengesellschaft | 27.49B |
| Fresenius SE & Co. KGaA | 26.87B |
| Fresenius Medical Care AG | 13.48B |
| Sartorius Aktiengesellschaft | 13.36B |
| Fielmann Group AG | 4.27B |
| Carl Zeiss Meditec AG | 3.74B |